Inactivation of the cytotoxic activity of repin, a sesquiterpene lactone from Centaurea repens

Chemical Research in Toxicology

Volumn 17, Issue 9, 2004, Pages 1170-1176

  Tukov, Francis F ^a   Anand, S ^b   Gadepalli, Rama Sarma V S ^b   Gunatilaka, A A Leslie ^c   Matthews, John C ^a   Rimoldi, John M ^b  

^a UNIVERSITY OF MISSISSIPPI   (United States)

^b UNIVERSITY OF MISSISSIPPI   (United States)

^c UNIVERSITY OF ARIZONA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUTATHIONE; REPIN; SESQUITERPENE LACTONE DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CENTAUREA; CENTAUREA REPENS; CHEMICAL STRUCTURE; CYTOTOXICITY; DRUG ISOLATION; NEUROTOXICITY; NONHUMAN; PHYTOCHEMISTRY; RAT;

ANIMALS; CELL SURVIVAL; CENTAUREA; CYTOTOXINS; DOSE-RESPONSE RELATIONSHIP, DRUG; PC12 CELLS; RATS; SESQUITERPENES; STRUCTURE-ACTIVITY RELATIONSHIP; TOXICITY TESTS;

ACROPTILON; ACROPTILON REPENS; ANIMALIA; CENTAUREA; CENTAUREA SOLSTITIALIS; EQUIDAE;

EID: 4644248952     PISSN: 0893228X     EISSN: None     Source Type: Journal    
DOI: 10.1021/tx049864e     Document Type: Article

References (41)

1. Cordy, D. R. (1978) Centaurea species and equine nigropallidal encephalomalacia. In Effects of Poisonous Plants on Livestock (Keeler, R. F., Van Kampen, K. R., and James, L. F., Eds.) pp 327-336, Academic Press, New York.
2. Young, S., Brown, W. W., and Klinger, B. (1970) Nigropallidal encephalomalacia in horses fed Russian knapweed-Centaurea repens L. Am. J. Vet. Res. 31, 1393-404.
3. Robles, M., Wang, N., Kim, R., and Choi, B. H. (1997) Cytotoxic effects of repin, a principal sesquiterpene lactone of Russian knapweed. J. Neurosci. Res. 47, 90-97.
4. Wang, Y., Hamburger, M., Cheng, C. H. K., Costall, B., Naylor, R. J., Jenner, P., and Hostettmann, K. (1991) Neurotoxic sesquiterpenoids from the yellow star thistle Centaurea solstitialis L. (Asteraceae). Helv. Chim. Acta 74, 117-123.
5. Robles, M., Aregullin, M., West, J., and Rodriguez, E. (1995) Recent studies on the zoopharmacognosy, pharmacology and neurotoxicology of sesquiterpene lactones. Planta Med. 61, 199-203.
6. Ivie, G. W., and Witzel, D. A. (1983) Sesquiterpene lactones: Structure, biological action, and toxicological significance. In Handbook of Natural Toxins (Keeler, F. R., and Tut A., Eds.) pp 543-584, Marcel Dekker, New York.
7. Rodriguez, E., Towers, G. H. N., and Mitchell, J. C. (1976) Biological activities of sesquiterpene lactones. Phytochemistry 15, 1573-1580.
8. Hay, A. J., Hamburger, M., Hostettmann, K., and Hoult, J. R. (1994) Toxic inhibition of smooth muscle contractility by plant-derived sesquiterpenes caused by their chemically reactive α-methylenebutyrolactone functions. Br. J. Pharmacol. 112, 9-12.
9. Heinrich, M., Robles, M., West, J. E., Ortiz de Montellano, B. R., and Rodriguez, E. (1998) Ethanopharmacology of Mexican Asteraceae (Compositae). Annu. Rev. Pharmacol. Toxicol. 38, 539-565.
10. Siedle, B., Cisielski, S., Murillo, R., Loser, B., Castro, V., Klaas, C. A., Hucke, O., Labahn, A., Melzig, M. F., and Merfort, I. (2002) Sesquiterpene lactones as inhibitors of human neutrophil elastase. Bioorg. Med. Chem. 10, 2855-2861.
11. Kupchan, S. M., Fessler, D. C., Eakin, M. A., and Giacobbe, T. J. (1970) Reactions of alpha methylene lactone tumor inhibitors with model biological nucleophiles. Science 168, 376-378.
12. Stevens, K. L. (1982) Sesquiterpene lactones from Centaurea repens. Phytochemistry 21, 1093-1098.
13. Stevens, K. L., Riopelle, R. J., and Wong, R. Y. (1990) Repin, a sesquiterpene lactone from Acroptilon repens possessing exceptional biological activity. J. Nat. Prod. 53, 218-221.
14. Robles, M., Choi, B. H., Han, B., Santa Cruz, K., and Kim, R. C. (1998) Repin-induced neurotoxicity in rodents. Exp. Neurol. 152, 129-136.
15. Reed, D. J., and Fariss, M. W. (1984) Glutathione depletion and susceptibility. Pharmacol. Rev. 36, 25S-33S.
16. Durham, H. D., O'Brien, C., Nalbantoglu, J., and Figlewicz, D. A. (1995) Use of tissue culture models to study environmental-genetic interactions relevant to neurodegenerative diseases. Clin. Exp. Pharm. Phys. 22, 366-367.
17. Geldof, A. A., Mastbergen, S. C., Henrar, R. E., and Faircloth, G. T. (1999) Cytotoxicity and neurocytotoxicity of new marine anticancer agents evaluated using in vitro assays. Cancer Chemother. Pharmacol, 44, 312-318.
18. Rizzardini, M., Lupi, M., Bernasconi, S., Mangolini, A., and Cantoni, L. (2003) Mitochondrial dysfunction and death in motor neurons exposed to the glutathione-depleting agent ethacrynic acid. J. Neurol. Sci. 207, 51-58.
19. Manev, H., Kharlamov, E., Uz, T., Mason, R. P., and Cagnoli, C. M. (1997) Characterization of zinc-induced neuronal death in primary cultures of rat cerebellar granule cells. Exp. Neurol. 146, 171-178.
20. Mosmann, T. (1983) Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods 65, 55-64.
21. Binienda, Z., Fogle, C. M., Slikker, W., and Ali, S. F. (1994) Acute effects of perinatal hypoxic insult on concentrations of dopamine, serotonin, and metabolites in fetal monkey brain. Int. J. Dev. Neurosci. 12, 127-131.
22. 2O. J. Chem. Res., Synop. 12, 768-769.
23. Schmidt, T. J. (1997) Helenanolide-type sesquiterpene lactones-III. Rates and stereochemistry in the reaction of helenalin and related helenanolides with sulfhydryl containing biomolecules. Bioorg. Med. Chem. 5, 645-653.
24. Mytilineou, C., and Cohen, G. (1984) 1-Methyl-4-phenyl-1,2,3,6- tetrahydropyridine destroys dopamine neurons in explants of rat embryo mesencephalon. Science 225, 529-531.
25. Friedman, L., and Mytilineou, C. (1987) The toxicity of MPTP to dopamine neurons in culture is reduced at high concentrations. Neurosci. Lett. 79, 65-72.
26. Mytilineou, C., and Friedman, L. (1988) Studies on the metabolism and toxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in cultures of embryonic rat mesencephalon. J. Neurochem. 51, 750-755.
27. Michel, P. P., Dandapani, B. K., Sanchez-Ramos, J., Efange, S., Pressman, B. C., and Hefti, F. (1989) Toxic effects of potential environmental neurotoxins related to 1-methyl-4-phenylpyridinium on cultured rat dopaminergic neurons. J. Pharmacol. Exp. Ther. 248, 842-850.
28. Hynes, M. A., Poulsen, K., Armanini, M., Berkemeier, L., Phillips, H., and Rosenthal, A. (1994) Neurotrophin-4/5 is a survival factor for embryonic midbrain dopaminergic neurons in enriched cultures. J. Neurosci. Res. 37, 144-154.
29. Seegal, R. F., Brosch, K., Bush, B., Ritz, M., and Shain W. (1989) Effects of Arochlor 1254 on dopamine and norepinephrine concentrations in pheochromocytoma (PC-12) cells. Neurotoxicology 10, 757-764.
30. Kittner, B., Brautigam, M., and Herken, H. (1987) PC12 cells: a model system for studying drug effects on dopamine synthesis and release. Arch. Int. Pharmacodyn. Ther. 286, 181-194.
31. Greene, L. A., and Rein, G. (1977) Release of (3H)norepinephrine from a clonal line of pheochromocytoma cells (PC12) by nicotinic cholinergic stimulation. Brain Res. 138, 521-528.
32. Brautigam, M., Kittner, B., and Herken, H. (1985) Evaluation of neurotropic drug actions on tyrosine hydroxylase activity and dopamine metabolism in clonal cell lines. Arzneimittelforschung 35, 277-284.
33. Teng, K. K., Georgieff, I. S., Aletta, J. M., Nunez, J., Shelanski, M. L., and Greene, L. A. (1993) Characterization of a PC12 cell sub-clone (PC12-C41) with enhanced neurite outgrowth capacity: Implications for a modulatory role of high molecular weight tau in neuritogenesis. J. Cell Sci. 106, 611-626.
34. Plummer, J. L., Smith, B. R., Sies, H., and Bend, J. R. (1981) Chemical depletion of glutathione in vivo. Methods Enzymol. 77, 50-59.
35. Seyfried, J., Soldner, F., Schulz, J. B., Klockgether, T., Kovar, K. A., and Wüllner, U. (1999) Differential effects of L-buthionine sulfoximine and ethacrynic acid on glutathione levels and mitochondrial function in PC12 cells. Neurosci. Lett. 264, 1-4.
36. Wüllner, U., Seyfried, J., Groscurth, P., Beinroth, S., Winter, S., Gleichmann, M., Heneka, M., Löschmann, P., Schulz, J. B., Weller, M., and Klockgether, T. (1999) Glutathione depletion and neuronal cell death: The role of reactive oxygen intermediates and mitochondrial function. Brain Res. 826, 53-62.
37. Tukov, F. F., Rimoldi, J. M., and Matthews, J. C. (2004) Characterization of the role of glutathione in repin-induced mitochondrial dysfunction, oxidative stress and neurotoxicity in rat pheochromocytoma (PC12) cells, Neurotoxicology, in press.
38. Merad-Boudia, M., Nicole, A., Santiard-Baron, D., Saille, C., and Ceballos-Picot, I. (1998) Mitochondrial impairment as an early event in the process of apoptosis induced by glutathione depletion in neuronal cells: relevance to Parkinson's disease. Biochem. Pharmacol. 56, 645-655.
39. Jenner, P. (1993) Altered mitochondrial function, iron metabolism and glutathione levels in Parkinson's disease. Acta Neurol. Scand. Suppl. 146, 6-13.
40. Schulz, J. B., Jörg, L., Seyfried, J., and Dichgans, J. (2000) Glutathione, oxidative stress and neurodegeneration. Eur. J. Biochem. 267, 4904-4911.
41. Drukarch, B., Jongenelen, C. A. M., Schepens, E., Langeveld, C. H., and Johannes, C. (1996) Glutathione is involved in the granular storage of dopamine in rat PC12 pheochromocytoma cells: Implications for the pathogenesis of Parkinson's disease. J. Neurosci. 16, 6038-6045.